(Q28265315)

https://api.crossref.org/works/10.1038/SJ.ONC.1209877

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209877

Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209877

Mutation analysis of the CHK2 gene in breast carcinoma and other cancers

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209877

Cell-cycle checkpoints and cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209877

Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209877

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209877

Frequency of CHEK2*1100delC in New York breast cancer cases and controls

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1209877

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

21 April 2017

The Chk2 protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Mutation analysis of the CHK2 gene in families with hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

CHK2 kinase--a busy messenger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Chk1 and Chk2 kinases in checkpoint control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Checking on DNA damage in S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

CHEK2 is a multiorgan cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

A novel founder CHEK2 mutation is associated with increased prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Mutations in CHEK2 associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Limited relevance of the CHEK2 gene in hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

CHEK2 I157T associates with familial and sporadic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

CHEK2 1100delC and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

CHEK2 variant I157T may be associated with increased breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Differentiation-induced radioresistance in muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Analysis of CHK2 in vulval neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

CHEK2 variants associate with hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Alternative splicing and mutation status of CHEK2 in stage III breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

CHEK2 1100delC is not a risk factor for male breast cancer population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Targeting the checkpoint kinases: chemosensitization versus chemoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Colorectal cancer and theCHEK2 1100delC mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer DifferentiateBRCA2-Associated Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Increasing evidence that germline mutations inCHEK2 do not cause Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Screening hCHK2 for Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Analysis of familial male breast cancer for germline mutations in CHEK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

Concomitant inactivation of p53 and Chk2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

One pot conjugation of the polypeptides directed by phosphorus oxychloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

Analysis of CHEK2 gene for ovarian cancer susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

Association of two mutations in theCHEK2 gene with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

NBS1 is a prostate cancer susceptibility gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

Pathology of breast cancer in women with constitutional CHEK2 mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

Homozygosity for aCHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209877

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209877

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1025485247

0 references

Fatcat ID

release_tbiyoisravhbpbfvw7c6gbq2sq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tbiyoisravhbpbfvw7c6gbq2sq

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

16998506

1 reference

Consolidated OpenCitations Corpus – April 2017